Aethlon Medical, Inc.
(NASDAQ : AEMD)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Medical Specialties
symbolcompany%chnglast%shortavg$volume
DHRDanaher Corp.
1.64%142.520.7%$427.60m
MDTMedtronic Plc
0.14%111.400.6%$417.47m
ABTAbbott Laboratories
-0.28%84.030.8%$394.57m
TMOThermo Fisher Scientific, Inc.
1.44%305.321.0%$366.88m
BDXBecton, Dickinson & Co.
0.90%245.691.1%$340.65m
SYKStryker Corp.
0.76%206.611.3%$337.65m
BAXBaxter International, Inc.
0.72%81.701.8%$324.76m
ISRGIntuitive Surgical, Inc.
1.56%577.942.4%$322.44m
BSXBoston Scientific Corp.
0.34%42.441.1%$302.24m
EWEdwards Lifesciences Corp.
0.56%243.731.2%$283.76m
ALGNAlign Technology, Inc.
1.21%271.766.4%$270.05m
WMGIWright Medical Group NV
0.20%29.518.3%$266.42m
DXCMDexCom, Inc.
1.71%217.438.3%$264.08m
ABMDABIOMED, Inc.
4.62%186.313.3%$149.89m
PODDInsulet Corp.
-0.32%181.906.7%$147.91m

Company Profile

Aethlon Medical, Inc. is a therapeutic technology company, which focuses on addressing global health and biodefense needs. It develops Aethlon Hemopurifier, a medical device that targets the elimination of circulating viruses and tumor-secreted exosomes that promote cancer progression. The firm operates through two segments: Aethlon and ESI. The Aethlon segment involves in therapeutic business activities. The ESI segment consists of diagnostic business activities. The company was founded by James A. Joyce in May 1998 and is headquartered in San Diego, CA.